Clinical Trial Update: Comparison of Efficacy and Safety Psoralen Combined With Ultraviolet A (PUVA) Vs Tofacitinib in the Treatment of Generalized Vitiligo. [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1, not-yet-recruiting clinical trial comparing PUVA therapy versus tofacitinib for generalized vitiligo, sponsored by Hayat Abad Medical Complex …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• PUVA therapy (psoralen + ultraviolet A) (psoralen + ultraviolet A)
• Tofacitinib (tofacitinib)

Snippet

Sponsor: Hayat Abad Medical Complex, Peshawar | Conditions: Vitiligo, Generalized | EARLY_Phase 1 | Status: NOT_YET_RECRUITING